Back to Research Hub
Veradermics, Incorporated
MANE
$97.93-3.88 (-3.81%)
Veradermics, Incorporated functions as a biopharmaceutical enterprise focused on devising pioneering therapeutic interventions for various skin and cosmetic disorders. The company's development pipeline includes treatments for Pattern Hair Loss (PHL), impacting both adult and pediatric demographics.
StreetsValue research for Veradermics, Incorporated (MANE)
Members get the full report for Veradermics, Incorporated: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.